title: Attitudes toward Post-Trial Access to Medical Interventions: A Review of Academic Literature, Legislation, and International Guidelines.
abstract: There is currently no international consensus around post-trial obligations toward research participants, community members, and host countries. This literature review investigates arguments and attitudes toward post-trial access. The literature review found that academic discussions focused on the rights of research participants, but offered few practical recommendations for addressing or improving current practices. Similarly, there are few regulations or legislation pertaining to post-trial access. If regulatory changes are necessary, we need to understand the current arguments, legislation, and attitudes towards post-trial access and participants and community members. Given that clinical trials conducted in low-income countries will likely continue, there is an urgent need for consideration of post-trial benefits for participants, communities, and citizens of host countries. While this issue may not be as pressing in countries where participants have access to healthcare and medicines through public schemes, it is particularly important in regions where this may not be available.
authors.forename: Kori
authors.initials: K
authors.lastname: Cook
authors.forename: Jeremy
authors.initials: J
authors.lastname: Snyder
authors.forename: John
authors.initials: J
authors.lastname: Calvert
mesh_terms: D001290:Attitude; D002986:Clinical Trials as Topic / Q000941:ethics*; D055812:Community-Based Participatory Research / Q000941:ethics*; D032984:Ethics, Research; D017408:Guidelines as Topic; D006297:Health Services Accessibility / Q000941:ethics* / Q000331:legislation & jurisprudence; D006801:Humans; D007878:Legislation as Topic; D028701:Patient Rights / Q000941:ethics*; D011203:Poverty
keywords: benefit sharing; clinical trials; drug trial; pharmaceutical; research ethics